Financial reports
ARS
2023 FY
Annual report to shareholders
15 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
17 Mar 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
29 Apr 22
Current reports
8-K
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
22 Feb 24
8-K
Regulation FD Disclosure
26 Jan 24
8-K
Lantheus Announces CEO Succession Plan
23 Jan 24
8-K
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
9 Jan 24
8-K
Lantheus Reports Third Quarter 2023 Financial Results
2 Nov 23
8-K
Departure of Directors or Certain Officers
28 Aug 23
8-K
Other Events
18 Aug 23
8-K
Lantheus Reports Second Quarter 2023 Financial Results
3 Aug 23
8-K
Entry into a Material Definitive Agreement
4 May 23
8-K
Lantheus Reports First Quarter 2023 Financial Results
4 May 23
Registration and prospectus
S-8
Registration of securities for employees
16 May 23
S-8
Registration of securities for employees
12 May 22
S-8
Registration of securities for employees
4 Aug 21
S-8
Registration of securities for employees
26 Jun 20
424B3
Prospectus supplement
14 May 20
425
Business combination disclosure
12 May 20
425
Business combination disclosure
14 Apr 20
425
Business combination disclosure
2 Apr 20
424B3
Prospectus supplement
19 Mar 20
S-4/A
Registration of securities issued in business combination transactions (amended)
16 Mar 20
Proxies
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
DEFA14A
Additional proxy soliciting materials
17 Mar 23
DEF 14A
Definitive proxy
17 Mar 23
DEFA14A
Additional proxy soliciting materials
18 Mar 22
DEF 14A
Definitive proxy
18 Mar 22
DEFA14A
Additional proxy soliciting materials
18 Mar 21
DEF 14A
Definitive proxy
18 Mar 21
DEFA14A
Additional proxy soliciting materials
6 Apr 20
DEFA14A
Additional proxy soliciting materials
12 Mar 20
Other
SD
Conflict minerals disclosure
31 May 23
SD
Conflict minerals disclosure
31 May 22
SD
Conflict minerals disclosure
28 May 21
CT ORDER
Confidential treatment order
21 Dec 20
SD
Conflict minerals disclosure
29 May 20
CT ORDER
Confidential treatment order
14 Apr 20
EFFECT
Notice of effectiveness
19 Mar 20
CORRESP
Correspondence with SEC
16 Mar 20
CT ORDER
Confidential treatment order
27 Dec 19
UPLOAD
Letter from SEC
20 Nov 19
Ownership
4
Paul Blanchfield
19 Apr 24
4
Andrea Sabens
17 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
3
Amanda Michelle Morgan
4 Apr 24
4
Robert J. Jr. Marshall
19 Mar 24
4
Andrea Sabens
15 Mar 24
144
Notice of proposed sale of securities
15 Mar 24
144
Notice of proposed sale of securities
13 Mar 24
4
Paul Blanchfield
11 Mar 24
4
Perspective Therapeutics, Inc.
8 Mar 24